A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome
NCT00312754
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
70
Enrollment
INDUSTRY
Sponsor class
Stopped
insufficient enrollment
Conditions
HIV Infections
Interventions
DRUG:
Atazanavir
Sponsor
Bristol-Myers Squibb